Arterial Health Predicts Cardiovascular Disease Risk in Patients With SLE
Researchers studied the relationship between the total burden of arterial plaque and cardiovascular disease risk in patients with systemic lupus erythematosus.
Cardiovascular Disease
USPSTF Issues Recommendations on Aspirin Use to Prevent Cardiovascular Disease
These recommendations only apply to individuals who do not have a history of CVD and are not already taking daily aspirin.
Risk for Cardiovascular Disease Significantly Higher Among Patients With RA vs General Population
Researchers explored the association between rheumatoid arthritis and cardiovascular disease among US adults aged 20 years and older.
Little Variation in Risk for Acute Coronary Syndrome Among Patients With RA Initiating Different bDMARDs
Researchers assessed the risks for short-, intermediate-, and long-term acute coronary syndrome among patients with rheumatoid arthritis initiating treatment with biologic disease-modifying antirheumatic drugs.
Cereal Fiber Linked to Lower Inflammation, Cardiovascular Disease in Older Adults
Cereal fiber intake is associated with lower levels of various inflammatory markers and a lower risk of cardiovascular disease.
Risks vs Benefits of Statin Use Among Patients With Rheumatoid Arthritis
Researchers evaluated the effect of statin use on risk for cardiovascular disease, all-cause mortality, and type 2 diabetes in patients with rheumatoid arthritis.
Specialist-Led Model of Care Improves CVD Prevention in Patients With Psoriatic Disease
Dermatologists and patients with psoriatic disease have a positive view of a specialist-led model of care to improve cardiovascular disease prevention.
The Heart of the Issue in Gout and Associated Cardiac Disease
In recognition of American Heart Month 2022, Jasvinder Singh, MD, evaluates the association between gout and cardiac disease, based on published literature.
Postmenopausal Women With Loneliness May Be at Higher Risk for CVD
A study was done to examine the relationship between social isolation and cardiovascular disease in postmenopausal women.
Tofacitinib May Increase Risk for Cardiovascular Outcomes in Patients With RA With CV Risk Factors or History of CVD
Based on results from the ORAL Surveillance trial, researchers of this study assessed the risk for cardiovascular outcomes with tofacitinib in patients with rheumatoid arthritis.
- Loading...
Loading...
Next post in Rheumatoid Arthritis
Loading... 
Loading...